BASF Raises Pronova Bid to $900 Million to Persuade Rebels

BASF SE, the world’s biggest chemical maker, boosted its offer for Norwegian drug-ingredient maker Pronova BioPharma ASA by 8 percent to win support from investors holding out for more money.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.